J Jakobsen1, A N Pedersen, L Ovesen. 1. Danish Veterinary and Food Administration, Institute of Food Research and Nutrition, Søborg, Denmark.
Abstract
OBJECTIVE: To examine the age dependency of the urinary para-aminobenzoic acid (PABA) excretion, and if a delayed PABA excretion can be overcome by advancing intake schedule; and to examine the recovery of PABA in fractionated urinary samples collected during 24 h after single and repeated doses of PABA. DESIGN: Cross-over study with subjects randomized to start with recommended schedule of PABA administration (80 mg at 08:00, 12:00 and 18:00; PABA18) and then an advanced schedule (80 mg at 08:00, 12:00 and 15:00; PABA15) or vice versa. One subgroup of eight subjects collected individual urine specimens for 24 h after a morning dose of 80 mg of PABA, and another subgroup of 10 subjects collected individual urine specimens for 24 h after ingestion of 80 mg of PABA three times at mealtimes. SUBJECTS: Employees and relatives from the Danish Food Administration. SETTING: Ninety-nine healthy volunteers (61 females and 38 males) aged 30-91 y. RESULTS: Linear regressions for PABA15 and PABA18 demonstrate significantly less recovery with age (PABA15: r(2)=0.1784, P=0.0002; PABA18: r(2)=0.1273, P=0.0019). Linear regression of DeltaPABA (PABA15-PABA18) with age showed the best fit line to be horizontal (slope -0.0066, P=0.89; 95% CI -0.1046, 0.0915) and with a Y-intercept not significantly different from 0 (1.575; 95% CI -4.176, 7.326). In this population the lower limit for complete 24 h urine collection was 79.2%. After a single dosage of 80 mg PABA 70-85% was recovered after 8 h. Within 16 h after ingestion of 240 mg PABA at recommended hours the lowest acceptable recovery (78.1%) was reached. CONCLUSION: There is a gradual decline of PABA recovery with age that cannot be overcome by advancing the dosage schedule. Because of a lower delimiting PABA recovery for the elderly, some 24 h collections in this age group will be rejected unjustly (false-negatives). Also, with the currently recommended dosage schedule (PABA taken with the main meals) the risk of false-positive 24 h urine collections prevails. With refinement of the PABA test procedure, ie employing a specific analytical method and age-dependent cut-off values, the test may achieve a higher specificity and sensitivity.
RCT Entities:
OBJECTIVE: To examine the age dependency of the urinary para-aminobenzoic acid (PABA) excretion, and if a delayed PABA excretion can be overcome by advancing intake schedule; and to examine the recovery of PABA in fractionated urinary samples collected during 24 h after single and repeated doses of PABA. DESIGN: Cross-over study with subjects randomized to start with recommended schedule of PABA administration (80 mg at 08:00, 12:00 and 18:00; PABA18) and then an advanced schedule (80 mg at 08:00, 12:00 and 15:00; PABA15) or vice versa. One subgroup of eight subjects collected individual urine specimens for 24 h after a morning dose of 80 mg of PABA, and another subgroup of 10 subjects collected individual urine specimens for 24 h after ingestion of 80 mg of PABA three times at mealtimes. SUBJECTS: Employees and relatives from the Danish Food Administration. SETTING: Ninety-nine healthy volunteers (61 females and 38 males) aged 30-91 y. RESULTS: Linear regressions for PABA15 and PABA18 demonstrate significantly less recovery with age (PABA15: r(2)=0.1784, P=0.0002; PABA18: r(2)=0.1273, P=0.0019). Linear regression of DeltaPABA (PABA15-PABA18) with age showed the best fit line to be horizontal (slope -0.0066, P=0.89; 95% CI -0.1046, 0.0915) and with a Y-intercept not significantly different from 0 (1.575; 95% CI -4.176, 7.326). In this population the lower limit for complete 24 h urine collection was 79.2%. After a single dosage of 80 mg PABA 70-85% was recovered after 8 h. Within 16 h after ingestion of 240 mg PABA at recommended hours the lowest acceptable recovery (78.1%) was reached. CONCLUSION: There is a gradual decline of PABA recovery with age that cannot be overcome by advancing the dosage schedule. Because of a lower delimiting PABA recovery for the elderly, some 24 h collections in this age group will be rejected unjustly (false-negatives). Also, with the currently recommended dosage schedule (PABA taken with the main meals) the risk of false-positive 24 h urine collections prevails. With refinement of the PABA test procedure, ie employing a specific analytical method and age-dependent cut-off values, the test may achieve a higher specificity and sensitivity.
Authors: Max Taubert; Mark Lückermann; Andreas Vente; Axel Dalhoff; Uwe Fuhr Journal: Antimicrob Agents Chemother Date: 2018-03-27 Impact factor: 5.191
Authors: Amy L Korth; Surabhi Bhutani; Marian L Neuhouser; Shirley A Beresford; Linda Snetselaar; Lesley F Tinker; Dale A Schoeller Journal: J Nutr Date: 2020-05-01 Impact factor: 4.798
Authors: Katherine A John; Mary E Cogswell; Norm R Campbell; Caryl A Nowson; Branka Legetic; Anselm J M Hennis; Sheena M Patel Journal: J Clin Hypertens (Greenwich) Date: 2016-01-03 Impact factor: 3.738
Authors: Valentina Forni Ogna; Adam Ogna; Philippe Vuistiner; Menno Pruijm; Belen Ponte; Daniel Ackermann; Luca Gabutti; Nima Vakilzadeh; Markus Mohaupt; Pierre-Yves Martin; Idris Guessous; Antoinette Péchère-Bertschi; Fred Paccaud; Murielle Bochud; Michel Burnier Journal: BMC Med Date: 2015-02-27 Impact factor: 8.775
Authors: Karen Charlton; Lisa J Ware; Elias Menyanu; Richard Berko Biritwum; Nirmala Naidoo; Chiné Pieterse; Savathree Lorna Madurai; Jeannine Baumgartner; George A Asare; Elizabeth Thiele; Aletta E Schutte; Paul Kowal Journal: BMJ Open Date: 2016-11-30 Impact factor: 2.692
Authors: Camilo A Ruiz-Bedoya; Alvaro A Ordonez; Rudolf A Werner; Donika Plyku; Mariah H Klunk; Jeff Leal; Wojciech G Lesniak; Daniel P Holt; Robert F Dannals; Takahiro Higuchi; Steven P Rowe; Sanjay K Jain Journal: J Nucl Med Date: 2020-03-20 Impact factor: 11.082